[Production of a new antibiotic, chalcidin, from Micromonospora chalcea culture].
D000596:Amino Acids / Q000032:analysis; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000032:analysis / Q000096:biosynthesis* / Q000302:isolation & purification / Q000494:pharmacology* / Q000627:therapeutic use; D001412:Bacillus subtilis / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects*; D002175:Candida / Q000187:drug effects*; D002623:Chemistry Techniques, Analytical; D003470:Culture Media; D003864:Depression, Chemical; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000187:drug effects; D007709:Klebsiella / Q000187:drug effects; D008089:Listeria monocytogenes / Q000187:drug effects; D051379:Mice; D008847:Micromonospora / Q000378:metabolism*; D010455:Peptides / Q000032:analysis; D011008:Pneumococcal Infections / Q000188:drug therapy*; D012505:Sarcina / Q000187:drug effects; D012988:Soil Microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects
D000596:Amino Acids; D000900:Anti-Bacterial Agents; D003470:Culture Media; D010455:Peptides
Obrazovanie novogo antibiotika kha'tsidina kul'tureĭ Micromonospora chalcea.